Finally, to establish the role of cyclophilins in p53-mediated tumor regression in vivo, we tracked individual autochthonously arising tumors in live mice over time using μCT during daily CsA (15 mg/kg) treatments. This evidence concerns the gene TP53 and neoplasm.